The Parallax View

The Parallax View

Home
Archive
About

Sitemap - 2021 - The Parallax View

Q3 2021 13F Review + Composite Ticker List

$GLUE | Monte Rosa Therapeutics

$TLIS | Talis, the Dark Horse of Point-of-Care Testing?

CD47: Eating Up Cancer and Biobucks

Q2 2021 13F Review

$CCCC | C4 Therapeutics

Exclusive: $NRIX | Nurix Therapeutics

Exclusive: $KYMR | Kymera Therapeutics

Exclusive: $ARVN | Arvinas

You've Been Targeted for Termination

$INFI | Infinity Pharma's bet on PI3K-γ

From Germophobe to Germophile

Hello World

© 2025 Substack Inc
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share